Medicine and Dentistry
Arm
10%
Bladder Cancer
9%
Cancer Registry
5%
Cancer Staging
11%
Cancer Therapy
9%
Carboplatin
10%
Chemotherapy
11%
Cisplatin
12%
Clinical Feature
9%
Cystectomy
9%
Diagnosis
11%
Ganglioglioma
7%
Gemcitabine
10%
Glioblastoma
9%
Hospital
13%
Immune Checkpoint Inhibitor
38%
Immunotherapy
20%
Inpatient
36%
Isocitrate Dehydrogenase
9%
Liver Metastasis
8%
Lung Cancer
15%
Malignant Neoplasm
14%
Malnutrition
9%
Muscle
9%
Muscle Invasive Bladder Cancer
9%
Neoadjuvant Chemotherapy
9%
Neoplasm
10%
Non Small Cell Lung Cancer
37%
Observational Study
10%
Oligoastrocytoma
9%
Overall Survival
25%
Patient
100%
Patient-Reported Outcome
9%
Personalized Medicine
9%
Proportional Hazards Model
9%
Protein Intake
10%
Randomized Controlled Trial
9%
Regression Analysis
5%
Skeletal Muscle
17%
Therapeutic Procedure
60%
Transitional Cell Carcinoma
9%
Pharmacology, Toxicology and Pharmaceutical Science
Carboplatin
9%
Chemotherapy
14%
Cisplatin
23%
Clinical Trial
7%
Gemcitabine
9%
Lung Cancer
9%
Malnutrition
9%
Phase II Trials
9%
Randomized Controlled Trial
5%
Transitional Cell Carcinoma
9%
Nursing and Health Professions
Adjuvant Therapy
9%
Body Composition
9%
Chemotherapy
5%
Compliance
6%
Control
7%
Lung Cancer
9%
Malnutrition
9%
Patient-Reported Outcome
9%
Woman
9%